SERPINB3 and hepatocellular carcinoma: An alternative group of biomarkers, include tumor associated antigens and antibodies such as squamous cell carcinoma antigen (SCCA) - and these biomarkers show potential, not only as a marker of early detection of HCC but may also help uncover new drug targets[82].